Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

American Axle seeks London listing as it progresses Dowlais takeover

(Sharecast News) - American Axle & Manufacturing will seek a secondary listing on the London Stock Exchange, it emerged on Friday, as it moves forward with its $1.4bn acquisition of Dowlais Group, the UK-based owner of GKN Automotive. The Detroit-based driveline systems supplier, already listed on the New York Stock Exchange, said the move would broaden access to the combined group's shares, allowing existing Dowlais shareholders and new investors in the UK to participate in the merged entity's future growth.

The cash-and-stock transaction, announced in January, valued Dowlais at £1.16bn and was expected to generate at least $300m in annual cost synergies within three years of completion.

American Axle said the integration process was progressing well, with regulatory filings advancing and US antitrust approval already secured.

The company emphasised that the combination would enhance scale and resilience amid a volatile automotive landscape, shaped by fluctuating electric vehicle demand, economic headwinds, and heightened competition from Chinese manufacturers.

American Axle also pointed to recent geopolitical developments, including a 25% US tariff on imported vehicles and a two-year window for increased domestic sourcing, as further strengthening the strategic rationale for the merger.

The secondary listing was not a condition of the deal, but both companies had amended their co-operation agreement to align the process with the planned combination timeline.

At 1043 BST, shares in Dowlais Group were down 1.25% at 66.41p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.